`
`
`
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`GENEDX, INC.
`Petitioner
`
`v.
`
`MYRIAD GENETICS, INC.
`Patent Owner
`
`
`
`
`
`
`
`
`
`
`
`
`Case 2014-01313
`Patent 6,051,379
`
`
`
`
`
`
`
`
`
`
`
`
`PATENT OWNER MYRIAD GENETIC’S
`MANDATORY NOTICES
`
`
`
`Case 2014-01313
`Attorney Docket No: 28496-0022IP1
`
`
`
`
`
`PATENT OWNER’S MANDATORY NOTICES
`UNDER 37 C.F.R. § 42.8
`
`Pursuant to 37 C.F.R. § 42.8, the patent owner, MYRIAD GENETICS, INC.
`
`(“Patent Owner”), hereby submits the following Mandatory Notices in response to
`
`the Petition for Inter Partes Review of U.S. Patent No. 6,051,379.
`
`1.
`
`Real Party-In-Interest under 37 CFR § 42.8(b)(1)
`
`MYRIAD GENETICS, INC. is the Patent Owner and the Real Party-In-
`
`Interest in this proceeding.
`
`2.
`
`Related Matters under 37 CFR § 42.8(b)(2)
`
`The following judicial or administrative matters may affect or be affected by
`
`a decision in this proceeding:
`
`Judicial matters: The '379 patent has been asserted against GENEDX in
`
`Univ. of Utah Research Foundation et al. v. GeneDx, No. 2-13-cv-00954 (D. Utah
`
`Oct. 16, 2013) and against others in cases consolidated into: In Re: BRCA1- and
`
`BRCA2- Based Hereditary Cancer Test Patent Litigation, No. 2-14-md-02510 (D.
`
`Utah Feb. 25, 2014); Invitae Corporation v. Myriad Genetics, Inc., No. 3-13-cv-
`
`05495 (N. D. Cal. Nov. 26, 2013); Quest Diagnostics Inc. et al. v. Myriad
`
`Genetics, Inc., No. 8-13-cv-01587 (C. D. Cal. Oct. 10, 2013); Counsyl, Inc v.
`
`Myriad Genetics, Inc., 5-13-cv-04391 (N. D. Cal. Sep. 20, 2013); Univ. of Utah
`
`Research Foundation et al v. Gene by Gene, Ltd., No. 2-13-cv-00643 (D. Utah Jul.
`
`2
`
`
`
`Case 2014-01313
`Attorney Docket No: 28496-0022IP1
`10, 2013). GDX1030. Administrative matters: Petitioner GeneDx filed Petitions
`
`for IPR on August 18, 2014 of U.S. Patent Nos. 5,654,155; 5,753,441; 6,033,857;
`
`6,083,698; and 6,951,721 concurrently with the ‘379 petition.
`
`3.
`
`Lead and Back-Up Counsel, under 37 CFR § 42.8(b)(3)
`
`The Patent Owner designates the following lead and back-up counsel:
`
`LEAD COUNSEL
`Dorothy P. Whelan, Reg. No. 33,814
`3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Tel: (612) 337-2509
`Email: Whelan@fr.com
`Fax:
` (202) 783-2331
`
`4.
`
`BACK-UP COUNSEL
`J. Patrick Finn, III, Reg. No. 44,109
`3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Tel: (612) 337-2509
`Email: IPR28496-0022IP1@fr.com
`Fax: (202) 783-2331
`
`Service Information under 37 CFR § 42.8(b)(4)(i) et seq.
`
`Please address all correspondence and service to both counsel as listed
`
`above. Patent Owner consents to service by email at IPR28496-0022IP1@fr.com
`
`(ref.: Docket No. 28496-0022IP).
`
`
`
`
`
`Date:/September 8, 2014/
`
`
`Customer Number 26171
`Fish & Richardson P.C.
`Telephone: (612) 337-2508
`Facsimile: (612) 288-9696
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/Dorothy P. Whelan/
`Dorothy P. Whelan
`Reg. No. 33,814
`
`
`
`3
`
`
`
`Case 2014-01313
`Attorney Docket No: 28496-0022IP1
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 CFR §§ 42.6(e)(4) and 42.205(b), the undersigned certifies
`
`that on September 8, 2014, a complete and entire copy of this Patent Owner
`
`MYRIAD GENETIC’s Mandatory Notices and Power of Attorney were provided
`
`via email, to the Petitioner by serving the correspondence address of record as
`
`follows:
`
`Eldora L. Ellison
`Deborah A. Sterling
`Ralph W. Powers III
`Sterne, Kessler, Goldstein & Fox, P.L.L.C.
`1100 New York Avenue, NW
`Washington, DC 20005
`
`Email: eellison-PTAB@skgf.com
`dsterlin-PTAB@skgf.com
`tpowers-PTAB@skgf.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`4
`
`
`
` /Susan C. Johnson/
`Susan C. Johnson
`Fish & Richardson P.C.
`60 South Sixth Street, Suite 3200
`Minneapolis, MN 55402
`(214) 292-4086
`
`